How to Buy shilpamed Shares on Fincept?
You can buy Shilpa Medicare Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Shilpa Medicare Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Shilpamed, including updates on board meetings and corporate actions.
Shilpa Medicare Limited - https://www.vbshilpa.com
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetate, bendamustine HCL monohydrate, bicalutamide, bortezomib, busulphan, cabazitaxel amorphous, capecitabine, clofarabine, cyclophosphamide, dasatinib, decitabine, dimethyl fumarate, erlotinib HCL, enzalutamide, fingolimod hydrochloride, gemcitabine HCl, ibrutinib, imatinib mesylate, irinotecan HCl trihydrate, lenalidomide, lenvatinib mesylate, letrozole, and melphalan HCL. Its APIs also include nifedipine, oxaliplatin, pazopanib, pemetrexed disodium hemipentahydrate, pemetrexed dipotassium nonahydrate, pirfenidone, pomalidomide, sodium cholesteryl sulfate, sorafenib tosylate, sunitinib malate, temozolomide, teriflunomide, thalidomide, tranexamic and zoledronic acid, phenylephrine, citicholine, palbocicilib, nilotinib, nintedanib, praziquintol, carmustine, elthrombopag olamine, abacavir sulphate, tenofovir disproxyl fumarate API, tenofovir alfanamide, prucalopride succinate, and varenicline tartrate. In addition, the company provides intermediates; high-purity multi-cyclic and long-chain peptides; specialty and biopolymers; biologics; contract development and manufacturing services; and formulations, such as tablets, capsules, liquid injections, dry powder injectable products, orally disintegrating films, transdermal patches, and lyophilized injectables. Further, it is involved in the manufacture of specialized oncology formulations; and wind power generation activities. The company was formerly known as Shilpa Antibiotics Ltd and changed its name to Shilpa Medicare Limited in February 2003. Shilpa Medicare Limited was incorporated in 1987 and is based in Raichur, India.
Shilpa Medicare Limited Share Price Today
721.70
OPEN
745.65
HIGH
699.05
LOW
705.25
CLOSE
186 K
VOLUME
7,757 Cr
Market Cap
360548
Average Volume
Healthcare
Sector
NSI
Exchange
Shilpa Medicare Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: SHILPAMED Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Shilpa Medicare Limited |
SHILPAMED |
INE790G01023 |
Annual General Meeting |
06 Sep 2024 |
1 |
N/A |
Shilpa Medicare Limited |
SHILPAMED |
INE790G01023 |
Annual General Meeting |
22 Sep 2023 |
1 |
N/A |
Shilpa Medicare Limited |
SHILPAMED |
INE790G01023 |
Annual General Meeting/Dividend - Rs 1.10 Per Share |
19 Sep 2022 |
1 |
N/A |
Shilpa Medicare Limited |
SHILPAMED |
INE790G01023 |
Dividend - Rs 1.10 Per Share |
20 Sep 2021 |
1 |
N/A |
Shilpa Medicare Limited |
SHILPAMED |
INE790G01023 |
Annual General Meeting |
20 Sep 2021 |
1 |
N/A |
NSE: SHILPAMED Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
SHILPAMED |
30 Dec 2024, 12:55:47 |
Trading Window-XBRL |
Pharmaceuticals |
SHILPAMED |
30 Dec 2024, 12:55:20 |
Trading Window-XBRL |
Pharmaceuticals |
SHILPAMED |
30 Dec 2024, 12:54:07 |
Trading Window |
Pharmaceuticals |
SHILPAMED |
27 Dec 2024, 11:36:44 |
General Updates |
Pharmaceuticals |
SHILPAMED |
20 Dec 2024, 14:14:35 |
General Updates |
Pharmaceuticals |
NSE: SHILPAMED Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Shilpa Medicare Limited |
SHILPAMED |
11 Oct 2024, 14:53:00 |
11 Oct 2024, 14:53:00 |
|
Shilpa Medicare Limited |
SHILPAMED |
12 Jul 2024, 17:37:00 |
12 Jul 2024, 17:37:00 |
|
Shilpa Medicare Limited |
SHILPAMED |
11 Apr 2024, 17:06:00 |
11 Apr 2024, 17:30:00 |
|
Shilpa Medicare Limited |
SHILPAMED |
09 Jan 2024, 18:00:00 |
09 Jan 2024, 18:30:00 |
|
Shilpa Medicare Limited |
SHILPAMED |
14 Oct 2023, 13:46:00 |
14 Oct 2023, 14:15:00 |
NSE: SHILPAMED Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson Related To Promoters,Non-Executive Director |
15 Dec 1956 |
23 Mar 1988 |
01301385 |
OM PRAKASH INNANI |
Active |
Executive Director-MD |
25 Sep 1962 |
20 Nov 1987 |
01243391 |
VISHNUKANT CHATURBHUJ BHUTADA |
Active |
Executive Director |
25 Aug 1967 |
01 Oct 2019 |
03603460 |
SHARATH REDDY KALAKOTA |
Active |
Independent Director |
29 Jul 1965 |
02 Sep 2021 |
00106895 |
HETAL MADHUKANT GANDHI |
Active |
Independent Director |
18 Feb 1960 |
02 Sep 2021 |
00669039 |
ARVIND VASUDEVA |
Active |
NSE: SHILPAMED Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
Board Meeting Intimation |
SHILPAMED |
N/A |
INE790G01023 |
Shilpa Medicare Limited |
04 Nov 2024, 12:21:44 |
SHILPA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 08-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . |
SHILPAMED |
N/A |
INE790G01023 |
Shilpa Medicare Limited |
31 Jul 2024, 14:18:34 |
SHILPA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 23-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend. |
SHILPAMED |
N/A |
INE790G01023 |
Shilpa Medicare Limited |
16 May 2024, 14:46:30 |
Financial Results |
SHILPAMED |
N/A |
INE790G01023 |
Shilpa Medicare Limited |
01 Feb 2024, 13:32:03 |
SHILPA MEDICARE LIMITED has informed the Exchange about Board Meeting to be held on 10-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2023 . |
SHILPAMED |
N/A |
INE790G01023 |
Shilpa Medicare Limited |
03 Nov 2023, 13:53:02 |
NSE: SHILPAMED Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results |
SHILPAMED |
- |
INE790G01023 |
Shilpa Medicare Limited |
04 Nov 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 |
Financial Results |
SHILPAMED |
- |
INE790G01023 |
Shilpa Medicare Limited |
31 Jul 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 |
Financial Results/Dividend |
SHILPAMED |
- |
INE790G01023 |
Shilpa Medicare Limited |
16 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and dividend |
Fund Raising |
SHILPAMED |
- |
INE790G01023 |
Shilpa Medicare Limited |
05 Feb 2024, 00:00:00 |
To consider Fund Raising |
Financial Results |
SHILPAMED |
- |
INE790G01023 |
Shilpa Medicare Limited |
01 Feb 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 |
NSE: SHILPAMED Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Capital Lease Obligations | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Preferred Securities Outside Stock Equity | Non Current Pension And Other Postretirement Benefit Plans | Tradeand Other Payables Non Current | Non Current Deferred Revenue | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Capital Lease Obligation | Current Debt | Pensionand Other Post Retirement Benefit Plans Current | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Financial Assets | Investmentin Financial Assets | Held To Maturity Securities | Available For Sale Securities | Long Term Equity Investment | Investmentsin Joint Venturesat Cost | Investments In Other Ventures Under Equity Method | Investmentsin Associatesat Cost | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Assets Held For Sale Current | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Allowance For Doubtful Accounts Receivable | Gross Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 97,790,908.00 | 97,790,908.00 | 4,720,413,000.00 | 4,905,912,000.00 | 18,031,724,000.00 | 28,169,262,000.00 | 3,645,591,000.00 | 18,031,724,000.00 | 15,448,000.00 | 23,278,798,000.00 | 25,919,685,000.00 | 23,191,849,000.00 | -86,949,000.00 | 23,278,798,000.00 | 23,181,007,000.00 | 0.00 | 0.00 | 97,791,000.00 | 97,791,000.00 | 7,981,437,000.00 | 3,036,591,000.00 | 152,066,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,655,199,000.00 | 14,312,000.00 | 2,640,887,000.00 | 229,326,000.00 | 4,944,846,000.00 | 376,827,000.00 | 2,250,713,000.00 | 1,136,000.00 | 2,249,577,000.00 | 0.00 | 292,594,000.00 | 971,042,000.00 | 0.00 | 0.00 | 0.00 | 971,042,000.00 | 31,173,286,000.00 | 22,582,849,000.00 | 653,160,000.00 | 0.00 | 23,888,000.00 | 0.00 | 425,004,000.00 | 0.00 | 425,004,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5,247,074,000.00 | 4,784,766,000.00 | 462,308,000.00 | 16,233,723,000.00 | 0.00 | 16,233,723,000.00 | 4,552,868,000.00 | 11,680,855,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8,590,437,000.00 | 1,266,186,000.00 | 0.00 | 0.00 | 0.00 | 3,265,545,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 95,217,000.00 | 3,598,295,000.00 | 0.00 | 0.00 | 365,194,000.00 | 195,143,000.00 | 170,051,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 86,801,898.00 | 86,801,898.00 | 9,053,615,000.00 | 9,373,886,000.00 | 13,012,459,000.00 | 27,442,813,000.00 | 1,834,772,000.00 | 13,012,459,000.00 | 18,014,000.00 | 18,086,941,000.00 | 23,688,540,000.00 | 17,999,569,000.00 | -87,372,000.00 | 18,086,941,000.00 | 876,000.00 | 10,337,956,000.00 | 7,249,515,000.00 | 86,802,000.00 | 86,802,000.00 | 12,932,477,000.00 | 5,998,995,000.00 | 654,000.00 | 0.00 | 224,292,000.00 | 0.00 | 159,729,000.00 | 0.00 | 5,614,320,000.00 | 12,721,000.00 | 5,601,599,000.00 | 224,292,000.00 | 6,933,482,000.00 | 59,000.00 | 3,759,566,000.00 | 5,293,000.00 | 3,754,273,000.00 | 296,865,000.00 | 205,789,000.00 | 2,565,369,000.00 | 652,866,000.00 | 2,099,000.00 | 162,162,000.00 | 1,748,242,000.00 | 30,932,046,000.00 | 22,163,792,000.00 | 73,284,000.00 | 79,058,000.00 | 102,614,000.00 | 0.00 | 3,989,000.00 | 20,000.00 | 3,969,000.00 | 398,872,000.00 | 85,016,000.00 | 53,569,000.00 | 260,287,000.00 | 5,074,482,000.00 | 4,612,174,000.00 | 462,308,000.00 | 16,384,986,000.00 | -5,068,662,000.00 | 21,453,648,000.00 | 4,453,054,000.00 | 4,177,079,000.00 | 8,928,753,000.00 | 3,277,778,000.00 | 616,984,000.00 | 0.00 | 8,768,254,000.00 | 4,575,000.00 | 0.00 | 15,406,000.00 | 1,003,944,000.00 | 3,449,281,000.00 | 208,592,000.00 | 834,576,000.00 | 695,451,000.00 | 1,710,662,000.00 | 25,452,000.00 | 46,884,000.00 | 3,920,455,000.00 | 0.00 | 3,920,455,000.00 | 302,257,000.00 | 30,605,000.00 | 302,257,000.00 | 72,798,000.00 | 229,459,000.00 |
| 2024-03-31T00:00:00 | annual | 86,801,898.00 | 86,801,898.00 | 9,053,615,000.00 | 9,373,886,000.00 | 13,012,459,000.00 | 27,442,813,000.00 | 1,834,772,000.00 | 13,012,459,000.00 | 18,014,000.00 | 18,086,941,000.00 | 23,688,540,000.00 | 17,999,569,000.00 | -87,372,000.00 | 18,086,941,000.00 | 876,000.00 | 10,337,956,000.00 | 7,249,515,000.00 | 86,802,000.00 | 86,802,000.00 | 12,932,477,000.00 | 5,998,995,000.00 | 654,000.00 | 0.00 | 224,292,000.00 | 0.00 | 159,729,000.00 | 0.00 | 5,614,320,000.00 | 12,721,000.00 | 5,601,599,000.00 | 224,292,000.00 | 6,933,482,000.00 | 59,000.00 | 3,759,566,000.00 | 5,293,000.00 | 3,754,273,000.00 | 296,865,000.00 | 205,789,000.00 | 2,565,369,000.00 | 652,866,000.00 | 2,099,000.00 | 162,162,000.00 | 1,748,242,000.00 | 30,932,046,000.00 | 22,163,792,000.00 | 73,284,000.00 | 79,058,000.00 | 102,614,000.00 | 0.00 | 3,989,000.00 | 20,000.00 | 3,969,000.00 | 398,872,000.00 | 85,016,000.00 | 53,569,000.00 | 260,287,000.00 | 5,074,482,000.00 | 4,612,174,000.00 | 462,308,000.00 | 16,384,986,000.00 | -5,068,662,000.00 | 21,453,648,000.00 | 4,453,054,000.00 | 4,177,079,000.00 | 8,928,753,000.00 | 3,277,778,000.00 | 616,984,000.00 | 0.00 | 8,768,254,000.00 | 4,575,000.00 | 0.00 | 15,406,000.00 | 1,003,944,000.00 | 3,449,281,000.00 | 208,592,000.00 | 834,576,000.00 | 695,451,000.00 | 1,710,662,000.00 | 25,452,000.00 | 46,884,000.00 | 3,920,455,000.00 | 0.00 | 3,920,455,000.00 | 302,257,000.00 | 30,605,000.00 | 302,257,000.00 | 72,798,000.00 | 229,459,000.00 |
| 2023-09-30T00:00:00 | quarterly | 86,801,898.00 | 86,801,898.00 | 8,397,657,000.00 | 8,654,395,000.00 | 12,903,876,000.00 | 26,469,718,000.00 | 1,949,141,000.00 | 12,903,876,000.00 | 19,426,000.00 | 17,834,749,000.00 | 23,403,067,000.00 | 17,745,894,000.00 | -88,855,000.00 | 17,834,749,000.00 | 17,747,947,000.00 | 0.00 | 0.00 | 86,802,000.00 | 86,802,000.00 | 12,294,449,000.00 | 5,992,409,000.00 | 169,936,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24,113,000.00 | 5,587,744,000.00 | 19,426,000.00 | 5,568,318,000.00 | 210,616,000.00 | 6,302,040,000.00 | 192,348,000.00 | 3,066,651,000.00 | 0.00 | 3,066,651,000.00 | 0.00 | 250,073,000.00 | 1,858,928,000.00 | 0.00 | 0.00 | 11,015,000.00 | 1,847,913,000.00 | 30,040,343,000.00 | 21,789,163,000.00 | 853,200,000.00 | 0.00 | 0.00 | 0.00 | 514,637,000.00 | 0.00 | 514,637,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,930,873,000.00 | 4,475,606,000.00 | 455,267,000.00 | 15,490,453,000.00 | 0.00 | 15,490,453,000.00 | 3,890,930,000.00 | 11,599,523,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8,251,181,000.00 | 1,069,201,000.00 | 0.00 | 0.00 | 0.00 | 3,316,005,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3,553,873,000.00 | 0.00 | 0.00 | 312,102,000.00 | 74,790,000.00 | 237,312,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 86,801,898.00 | 86,801,898.00 | 7,744,036,000.00 | 7,978,888,000.00 | 12,971,025,000.00 | 25,789,988,000.00 | -148,931,000.00 | 12,971,025,000.00 | 21,670,000.00 | 17,832,770,000.00 | 20,720,959,000.00 | 17,743,565,000.00 | -89,205,000.00 | 17,832,770,000.00 | 876,000.00 | 10,011,804,000.00 | 7,249,515,000.00 | 86,802,000.00 | 86,802,000.00 | 11,295,699,000.00 | 3,451,222,000.00 | 3,256,000.00 | 0.00 | 176,490,000.00 | 50,000,000.00 | 174,765,000.00 | 140,508,000.00 | 2,906,203,000.00 | 18,014,000.00 | 2,888,189,000.00 | 176,490,000.00 | 7,844,477,000.00 | -3,000.00 | 5,072,685,000.00 | 3,656,000.00 | 5,069,029,000.00 | 291,495,000.00 | 209,245,000.00 | 2,127,639,000.00 | 551,484,000.00 | 2,464,000.00 | 145,690,000.00 | 1,428,001,000.00 | 29,039,264,000.00 | 21,343,718,000.00 | 515,000.00 | 68,347,000.00 | 0.00 | 0.00 | 109,219,000.00 | 20,000.00 | 109,199,000.00 | 426,362,000.00 | 397,231,000.00 | 29,131,000.00 | 0.00 | 4,861,745,000.00 | 4,406,478,000.00 | 455,267,000.00 | 15,877,530,000.00 | -4,376,406,000.00 | 20,253,936,000.00 | 4,083,038,000.00 | 4,214,912,000.00 | 8,327,486,000.00 | 3,015,324,000.00 | 613,176,000.00 | 0.00 | 7,695,546,000.00 | 3,199,000.00 | 0.00 | 3,864,000.00 | 871,524,000.00 | 3,198,210,000.00 | 210,061,000.00 | 652,435,000.00 | 520,969,000.00 | 1,814,745,000.00 | 65,022,000.00 | 88,317,000.00 | 3,243,491,000.00 | -3,254,000.00 | 3,243,491,000.00 | 221,919,000.00 | 8,737,000.00 | 213,182,000.00 | 14,899,000.00 | 198,283,000.00 |
| 2023-03-31T00:00:00 | annual | 86,801,898.00 | 86,801,898.00 | 7,744,036,000.00 | 7,978,888,000.00 | 12,971,025,000.00 | 25,789,988,000.00 | -148,931,000.00 | 12,971,025,000.00 | 21,670,000.00 | 17,832,770,000.00 | 20,720,959,000.00 | 17,743,565,000.00 | -89,205,000.00 | 17,832,770,000.00 | 876,000.00 | 10,011,804,000.00 | 7,249,515,000.00 | 86,802,000.00 | 86,802,000.00 | 11,295,699,000.00 | 3,451,222,000.00 | 3,256,000.00 | 0.00 | 176,490,000.00 | 50,000,000.00 | 174,765,000.00 | 140,508,000.00 | 2,906,203,000.00 | 18,014,000.00 | 2,888,189,000.00 | 176,490,000.00 | 7,844,477,000.00 | -3,000.00 | 5,072,685,000.00 | 3,656,000.00 | 5,069,029,000.00 | 291,495,000.00 | 209,245,000.00 | 2,127,639,000.00 | 551,484,000.00 | 2,464,000.00 | 145,690,000.00 | 1,428,001,000.00 | 29,039,264,000.00 | 21,343,718,000.00 | 515,000.00 | 68,347,000.00 | 0.00 | 0.00 | 109,219,000.00 | 20,000.00 | 109,199,000.00 | 426,362,000.00 | 397,231,000.00 | 29,131,000.00 | 0.00 | 4,861,745,000.00 | 4,406,478,000.00 | 455,267,000.00 | 15,877,530,000.00 | -4,376,406,000.00 | 20,253,936,000.00 | 4,083,038,000.00 | 4,214,912,000.00 | 8,327,486,000.00 | 3,015,324,000.00 | 613,176,000.00 | 0.00 | 7,695,546,000.00 | 3,199,000.00 | 0.00 | 3,864,000.00 | 871,524,000.00 | 3,198,210,000.00 | 210,061,000.00 | 652,435,000.00 | 520,969,000.00 | 1,814,745,000.00 | 65,022,000.00 | 88,317,000.00 | 3,243,491,000.00 | -3,254,000.00 | 3,243,491,000.00 | 221,919,000.00 | 8,737,000.00 | 213,182,000.00 | 14,899,000.00 | 198,283,000.00 |
| 2022-03-31T00:00:00 | annual | 86,801,898.00 | 86,801,898.00 | 6,480,833,000.00 | 6,832,885,000.00 | 13,778,178,000.00 | 25,041,071,000.00 | 2,756,582,000.00 | 13,778,178,000.00 | 13,762,000.00 | 18,221,948,000.00 | 21,757,972,000.00 | 18,111,470,000.00 | -110,478,000.00 | 18,221,948,000.00 | 876,000.00 | 10,432,049,000.00 | 7,249,514,000.00 | 86,802,000.00 | 86,802,000.00 | 10,643,514,000.00 | 4,528,152,000.00 | 192,660,000.00 | 0.00 | 0.00 | 50,000,000.00 | 192,660,000.00 | 547,375,000.00 | 3,547,354,000.00 | 11,330,000.00 | 3,536,024,000.00 | 190,763,000.00 | 6,115,362,000.00 | 24,440,000.00 | 3,285,531,000.00 | 2,432,000.00 | 3,283,099,000.00 | 312,020,000.00 | 224,606,000.00 | 2,094,739,000.00 | 505,912,000.00 | 2,834,000.00 | 125,547,000.00 | 1,460,446,000.00 | 28,754,984,000.00 | 19,883,041,000.00 | -3,000.00 | 70,327,000.00 | 0.00 | 0.00 | 130,883,000.00 | 20,000.00 | 130,863,000.00 | 319,476,000.00 | 319,476,000.00 | 0.00 | 7,734,000.00 | 4,443,770,000.00 | 3,986,583,000.00 | 457,187,000.00 | 14,913,786,000.00 | -3,556,328,000.00 | 18,470,114,000.00 | 2,777,744,000.00 | 4,368,651,000.00 | 8,073,626,000.00 | 2,962,820,000.00 | 287,273,000.00 | 0.00 | 8,871,944,000.00 | 1,000,123,000.00 | 0.00 | 2,834,000.00 | 344,914,000.00 | 3,552,384,000.00 | 293,024,000.00 | 753,823,000.00 | 449,394,000.00 | 2,056,143,000.00 | 28,597,000.00 | 741,666,000.00 | 3,863,259,000.00 | -39,337,000.00 | 3,902,595,000.00 | 338,290,000.00 | 24,613,000.00 | 338,290,000.00 | 34,489,000.00 | 303,801,000.00 |
| 2021-03-31T00:00:00 | annual | 81,526,898.00 | 81,526,898.00 | 7,212,184,000.00 | 8,459,309,000.00 | 11,214,770,000.00 | 23,227,306,000.00 | 2,992,655,000.00 | 11,214,770,000.00 | 18,669,000.00 | 14,786,666,000.00 | 19,528,635,000.00 | 14,674,966,000.00 | -111,700,000.00 | 14,786,666,000.00 | 876,000.00 | 9,915,106,000.00 | 4,286,393,000.00 | 81,527,000.00 | 81,527,000.00 | 11,648,690,000.00 | 5,613,661,000.00 | 1,000.00 | 260,000.00 | 154,757,000.00 | 50,000,000.00 | 178,001,000.00 | 472,824,000.00 | 4,757,818,000.00 | 15,849,000.00 | 4,741,969,000.00 | 154,757,000.00 | 6,035,029,000.00 | 15,440,000.00 | 3,701,491,000.00 | 2,820,000.00 | 3,698,671,000.00 | 278,901,000.00 | 133,086,000.00 | 1,224,298,000.00 | 452,961,000.00 | 2,608,000.00 | 96,193,000.00 | 672,536,000.00 | 26,323,656,000.00 | 17,295,973,000.00 | 414,000.00 | 176,840,000.00 | 0.00 | 17,427,000.00 | 20,000.00 | 20,000.00 | 392,759,000.00 | 212,161,000.00 | 212,161,000.00 | 0.00 | 0.00 | 3,571,896,000.00 | 3,129,918,000.00 | 441,978,000.00 | 13,308,234,000.00 | -2,892,867,000.00 | 16,201,101,000.00 | 3,383,661,000.00 | 3,008,586,000.00 | 7,148,320,000.00 | 2,407,938,000.00 | 252,596,000.00 | 0.00 | 9,027,684,000.00 | 1,000.00 | 837,830,000.00 | 323,608,000.00 | 271,424,000.00 | 3,168,373,000.00 | 201,505,000.00 | 886,016,000.00 | 341,272,000.00 | 1,739,580,000.00 | 102,564,000.00 | 920,448,000.00 | 2,174,980,000.00 | -5,304,000.00 | 2,180,284,000.00 | 1,228,456,000.00 | 321,000,000.00 | 1,228,456,000.00 | 1,093,206,000.00 | 135,250,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 261,688,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 54,381,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10,379,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -4,635,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: SHILPAMED Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Effect Of Exchange Rate Changes | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Net Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Interest Received Cfi | Dividends Received Cfi | Net Investment Purchase And Sale | Net Business Purchase And Sale | Sale Of Business | Purchase Of Business | Net PPE Purchase And Sale | Sale Of PPE | Purchase Of PPE | Capital Expenditure Reported | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Provisionand Write Offof Assets | Depreciation And Amortization | Depreciation | Gain Loss On Investment Securities | Net Foreign Currency Exchange Gain Loss | Gain Loss On Sale Of PPE | Gain Loss On Sale Of Business | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -492,221,000.00 | 0.00 | -1,845,605,000.00 | 304,254,000.00 | 0.00 | 190,714,000.00 | -41,750,000.00 | 155,290,000.00 | 467,750,000.00 | -1,000.00 | -923,690,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,396,718,000.00 | 163,711,000.00 | 1,233,007,000.00 | -1,665,844,000.00 | 120,985,000.00 | 13,840,000.00 | 0.00 | -65,064,000.00 | 44,936,000.00 | 110,000,000.00 | -65,064,000.00 | -1,845,605,000.00 | 120,985,000.00 | -1,845,605,000.00 | 0.00 | 1,353,384,000.00 | -411,518,000.00 | -836,217,000.00 | -65,647,000.00 | -103,784,000.00 | 343,272,000.00 | -251,071,000.00 | -758,987,000.00 | 889,218,000.00 | 79,672,000.00 | 1,078,699,000.00 | 1,078,699,000.00 | -72,048,000.00 | 8,530,000.00 | 0.00 | 0.00 | 543,407,000.00 |
| 2023-03-31T00:00:00 | annual | -467,438,000.00 | 0.00 | -2,266,674,000.00 | 190,714,000.00 | 0.00 | 256,223,000.00 | 3,397,000.00 | -68,906,000.00 | 457,980,000.00 | 1,000.00 | -579,191,000.00 | -95,482,000.00 | 0.00 | 0.00 | 0.00 | 1,138,094,000.00 | 1,412,623,000.00 | -274,529,000.00 | -2,326,122,000.00 | 12,087,000.00 | 12,762,000.00 | 5,000,000.00 | -89,297,000.00 | -89,297,000.00 | 0.00 | -89,297,000.00 | -2,266,674,000.00 | 12,087,000.00 | -2,266,674,000.00 | 0.00 | 1,799,236,000.00 | -323,748,000.00 | 1,027,705,000.00 | -21,993,000.00 | 68,117,000.00 | -23,228,000.00 | 354,173,000.00 | 650,636,000.00 | 560,725,000.00 | 60,297,000.00 | 954,990,000.00 | 954,990,000.00 | 2,648,000.00 | -40,639,000.00 | 0.00 | 0.00 | -382,795,000.00 |
| 2022-03-31T00:00:00 | annual | -2,266,928,000.00 | 2,968,396,000.00 | -3,318,261,000.00 | 253,390,000.00 | 1,000.00 | 1,228,457,000.00 | 0.00 | -975,068,000.00 | 828,583,000.00 | -1,000.00 | -413,798,000.00 | -89,680,000.00 | -89,680,000.00 | 2,968,396,000.00 | 2,968,396,000.00 | -1,630,498,000.00 | -415,572,000.00 | -1,214,926,000.00 | -2,854,984,000.00 | 316,359,000.00 | 20,142,000.00 | 10,002,000.00 | -173,464,000.00 | 284,127,000.00 | 284,127,000.00 | 0.00 | -3,312,150,000.00 | 6,111,000.00 | -3,318,261,000.00 | 0.00 | 1,051,333,000.00 | -344,827,000.00 | -719,912,000.00 | 312,627,000.00 | 196,929,000.00 | 837,257,000.00 | -384,010,000.00 | -1,682,715,000.00 | 376,881,000.00 | 0.00 | 798,019,000.00 | 798,019,000.00 | 16,022,000.00 | -37,970,000.00 | 0.00 | -87,911,000.00 | 1,022,648,000.00 |
| 2021-03-31T00:00:00 | annual | -3,073,143,000.00 | 0.00 | -3,542,421,000.00 | 1,233,402,000.00 | 1,000.00 | 443,143,000.00 | -1,432,000.00 | 790,258,000.00 | 4,363,741,000.00 | 0.00 | -218,687,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,586,544,000.00 | 781,305,000.00 | 3,805,239,000.00 | -4,042,761,000.00 | -123,000.00 | 19,666,000.00 | 4,847,000.00 | -556,831,000.00 | -15,993,000.00 | 608,400,000.00 | -624,393,000.00 | -3,494,327,000.00 | 48,094,000.00 | -3,542,421,000.00 | 0.00 | 469,278,000.00 | -476,000,000.00 | -1,062,862,000.00 | 272,691,000.00 | -339,581,000.00 | -63,022,000.00 | -1,063,432,000.00 | 130,482,000.00 | 178,813,000.00 | -70,164,000.00 | 539,766,000.00 | 539,766,000.00 | 5,768,000.00 | -10,823,000.00 | 0.00 | -608,400,000.00 | 1,950,520,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 1,000.00 | 0.00 | -1,787,000.00 | 0.00 | 0.00 | 69,500,000.00 | 0.00 | -206,398,000.00 | -206,398,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1,155,313,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -137,000.00 | 0.00 | 0.00 |
NSE: SHILPAMED Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Minority Interests | Net Income Including Noncontrolling Interests | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Write Off | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Depreciation Income Statement | Research And Development | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 0.59 | 0.00 | 243.99 | 1.95 | 1.95 | 31.87 | 107.87 | 407.55 | 245.94 | 138.07 | -90.43 | 83.73 | 1.38 | 30.51 | 31.87 | 1,016.95 | 1.25 | 8.68 | 8.68 | 0.00 | 0.00 | 31.87 | 31.87 | 0.00 | 31.87 | -0.08 | 31.96 | 31.96 | 22.39 | 54.34 | 5.28 | 1.95 | -6.67 | 4.72 | -90.43 | 8.08 | 83.73 | 1.38 | 133.89 | 609.39 | 151.61 | 107.87 | 107.87 | 30.96 | 24.70 | 2.87 | 21.84 | 1.25 | 743.28 | 407.55 | 1,150.84 | 1,150.84 |
| 2023-03-31T00:00:00 | annual | -0.20 | 0.00 | 114.54 | -1.07 | -1.07 | -32.53 | 95.50 | 416.84 | 113.47 | 17.98 | -56.89 | 56.25 | 1.76 | -31.67 | -32.53 | 1,048.04 | 1.01 | 8.68 | 8.68 | 0.00 | 0.00 | -32.53 | -32.53 | 0.00 | -32.53 | -1.56 | -30.97 | -30.97 | -7.31 | -38.28 | 14.07 | -1.07 | 0.26 | 0.80 | -56.89 | 2.40 | 56.25 | 1.76 | -4.60 | 631.20 | 160.85 | 95.50 | 95.50 | 49.10 | 32.15 | 2.62 | 29.53 | 1.01 | 626.60 | 416.84 | 1,043.45 | 1,043.45 |
| 2022-03-31T00:00:00 | annual | 0.53 | 0.00 | 221.23 | 1.77 | 1.77 | 60.66 | 79.80 | 384.10 | 223.00 | 143.20 | -38.92 | 40.93 | 2.07 | 59.43 | 60.66 | 1,014.22 | 1.16 | 8.35 | 8.35 | 0.00 | 0.00 | 60.66 | 60.66 | 0.00 | 60.66 | 0.08 | 60.58 | 60.58 | 41.68 | 102.26 | 10.77 | 1.77 | -7.19 | 5.42 | -38.92 | 0.06 | 40.93 | 2.07 | 125.83 | 630.12 | 161.81 | 79.80 | 79.80 | 55.06 | 60.89 | 5.66 | 55.23 | 1.16 | 755.95 | 384.10 | 1,140.05 | 1,140.05 |
| 2021-03-31T00:00:00 | annual | 18.41 | 0.00 | 197.24 | 73.49 | 73.49 | 147.78 | 53.98 | 270.77 | 270.74 | 216.76 | -18.43 | 21.71 | 3.44 | 92.69 | 147.78 | 780.85 | 1.46 | 8.15 | 8.15 | 0.00 | 0.00 | 147.78 | 147.78 | 0.00 | 147.78 | 1.58 | 146.20 | 146.20 | 48.85 | 195.05 | 12.47 | 73.49 | -74.02 | 0.53 | -18.43 | 0.16 | 21.71 | 3.44 | 119.30 | 510.09 | 128.92 | 53.98 | 53.98 | 33.81 | 47.64 | 11.92 | 35.72 | 1.46 | 629.39 | 270.77 | 900.16 | 900.16 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
6/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
6.67
P/E
118.74063
P/B
3.8009312
Dividend Yield
N/A
Market Cap
7,756.94 Cr.
Face Value
208.37
Book Value
208.37
ROE
3.78%
EBITDA Growth
273.80 Cr.
Debt/Equity
52.078
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of shilpamed?
The market capitalization of Shilpa Medicare Limited is ₹7,757 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Shilpa Medicare Limited?
The PE and PB ratios of Shilpa Medicare Limited are Not Available and 3.8009312 respectively as of 05 Feb 2025.
What is the 52 Week High of Shilpa Medicare Limited?
The 52-week high of Shilpa Medicare Limited is ₹959.5 as of 05 Feb 2025.
What is the 52 Week Low of Shilpa Medicare Limited?
The 52-week low of Shilpa Medicare Limited is ₹313.15 as of 05 Feb 2025.
What are the earnings per share (EPS) for Shilpa Medicare Limited?
The Earnings Per Share (EPS) of Shilpa Medicare Limited is ₹6.67 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Shilpa Medicare Limited?
The Return on Equity (ROE) of Shilpa Medicare Limited is 3.78% as per the most recent financial year data. Explore more on Fincept.